DK1005540T3 - IKK-beta-proteiner, nukleinsyrer og fremgangsmåder - Google Patents

IKK-beta-proteiner, nukleinsyrer og fremgangsmåder

Info

Publication number
DK1005540T3
DK1005540T3 DK98933095T DK98933095T DK1005540T3 DK 1005540 T3 DK1005540 T3 DK 1005540T3 DK 98933095 T DK98933095 T DK 98933095T DK 98933095 T DK98933095 T DK 98933095T DK 1005540 T3 DK1005540 T3 DK 1005540T3
Authority
DK
Denmark
Prior art keywords
ikk
beta
nucleic acids
methods
disclosed
Prior art date
Application number
DK98933095T
Other languages
English (en)
Inventor
David V Goeddel
John Woronicz
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Application granted granted Critical
Publication of DK1005540T3 publication Critical patent/DK1005540T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK98933095T 1997-07-01 1998-07-01 IKK-beta-proteiner, nukleinsyrer og fremgangsmåder DK1005540T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88711497A 1997-07-01 1997-07-01
US08/890,853 US5851812A (en) 1997-07-01 1997-07-10 IKK-β proteins, nucleic acids and methods
PCT/US1998/013783 WO1999001542A1 (en) 1997-07-01 1998-07-01 IKK-β PROTEINS, NUCLEIC ACIDS AND METHODS
EP98933095A EP1005540B1 (en) 1997-07-01 1998-07-01 Ikk-beta proteins, nucleic acids and methods

Publications (1)

Publication Number Publication Date
DK1005540T3 true DK1005540T3 (da) 2004-10-18

Family

ID=27128822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98933095T DK1005540T3 (da) 1997-07-01 1998-07-01 IKK-beta-proteiner, nukleinsyrer og fremgangsmåder

Country Status (10)

Country Link
US (3) US5851812A (da)
EP (1) EP1005540B1 (da)
JP (2) JP3472584B2 (da)
AT (1) ATE269402T1 (da)
AU (1) AU725477B2 (da)
CA (1) CA2294516C (da)
DE (1) DE69824597T2 (da)
DK (1) DK1005540T3 (da)
ES (1) ES2218839T3 (da)
WO (1) WO1999001542A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972674A (en) 1996-08-26 1999-10-26 Signal Pharmaceuticals, Inc. Stimulus-inducible protein kinase complex and methods of use therefor
JP4695735B2 (ja) * 1996-08-26 2011-06-08 シグナル ファーマシューティカルズ， エルエルシー 刺激誘導性Ｉ（κ）Ｂキナーゼ［ＩＫＫ］シグナルソーム
AU740622B2 (en) * 1997-02-25 2001-11-08 Regents Of The University Of California, The IkB kinase, subunits thereof, and methods of using same
US6235512B1 (en) * 1997-07-01 2001-05-22 Tularik Inc. IKK-α proteins, nucleic acids and methods
US6087169A (en) * 1997-08-04 2000-07-11 Smithkline Beecham Plc HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide
EP0897009A3 (en) * 1997-08-04 1999-06-09 Smithkline Beecham Plc HKABY60 polypeptides
US6242253B1 (en) * 1997-10-09 2001-06-05 Regents Of The University Of California IkB kinase, subunits thereof, and methods of using same
US6030834A (en) * 1997-12-30 2000-02-29 Chiron Corporation Human IKK-beta DNA constructs and cells
WO2000023091A2 (en) * 1998-10-15 2000-04-27 Bioimage A/S Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases
AU779893B2 (en) * 1998-12-10 2005-02-17 Signal Pharmaceuticals, Llc Human ubiquitin ligase E3 for the modulation of NF-Kappa B
UA73492C2 (en) * 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
JP2002537397A (ja) 1999-02-22 2002-11-05 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 抗炎症剤としての多環ヘテロ環式誘導体
EP1163236B1 (en) 1999-03-12 2005-11-09 Boehringer Ingelheim Pharmaceuticals Inc. Aromatic heterocyclic compounds as anti-inflammatory agents
HUP0202248A3 (en) 1999-03-12 2006-06-28 Boehringer Ingelheim Pharma Compounds useful as anti-inflammatory agents
MXPA02000314A (es) * 1999-07-09 2004-06-22 Boehringer Ingelheim Pharma Proceso novedoso para la sintesis de compuestos de urea substituidos con heteroarilo.
AU6898700A (en) 1999-08-10 2001-03-05 Joslin Diabetes Center Inc. Method for identifying compounds for treatment of insulin resistance
US6630312B2 (en) 1999-08-10 2003-10-07 Joslin Diabetes Center, Inc. Method for identifying compounds for treatment of insulin resistance
AU2007202315B2 (en) * 1999-09-30 2009-11-19 Yale University Anti-inflammatory compounds and uses thereof
US6864355B1 (en) * 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
EP1242616A2 (en) * 1999-12-06 2002-09-25 Axxima Pharmaceuticals Aktiengesellschaft Method for identification and quantification of kinase inhibitors
EP1248856A2 (de) * 1999-12-23 2002-10-16 Xantos Biomedicine AG Screening-verfahren für nukleinsäuren
US6525046B1 (en) 2000-01-18 2003-02-25 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds as antiinflammatory agents
US6608052B2 (en) 2000-02-16 2003-08-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US7049395B2 (en) * 2000-05-02 2006-05-23 Yale University Anti-inflammatory compounds and uses thereof
US20030044852A1 (en) * 2000-08-10 2003-03-06 Joslin Diabetes Center, Inc., A Massachusetts Corporation Methods for treatment of insulin resistance
US6869956B2 (en) * 2000-10-03 2005-03-22 Bristol-Myers Squibb Company Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
PL364111A1 (en) * 2001-02-01 2004-12-13 Bristol-Myers Squibb Company Methods of treating inflammatory and immune diseases using inhibitors of ikappab kinase (ikk)
DE10115073A1 (de) * 2001-03-27 2002-10-10 Procorde Gmbh Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren
WO2002082082A2 (en) * 2001-04-09 2002-10-17 Boehringer Ingelheim Pharmaceuticals, Inc. Fluorescence polarization assay
US20030118578A1 (en) * 2001-11-09 2003-06-26 Anthony Rosenzweig Methods for treating ischemic reperfusion injury using IkappaB kinase-beta inhibitors
EP1455791A1 (en) * 2001-12-11 2004-09-15 Boehringer Ingelheim Pharmaceuticals Inc. Method for administering birb 796 bs
US7041669B2 (en) * 2002-02-25 2006-05-09 Boehringer Ingelheim Pharmaceuticals, Inc. 1,4-benzofused urea compounds useful in treating cytokine mediated diseases
US8053243B2 (en) * 2004-04-12 2011-11-08 The University Of Vermont And State Agricultural College Detection of nitrosylated proteins
WO2007106884A2 (en) * 2006-03-15 2007-09-20 Theralogics, Inc. Methods of treating muscular wasting diseases using nf-kb activation inhibitors
CA2653451C (en) 2006-05-22 2015-12-29 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of ikk-b gene
HUE027463T2 (en) 2008-05-28 2016-09-28 Reveragen Biopharma Inc Non-hormonal steroid modulators of nf-kb for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4695735B2 (ja) * 1996-08-26 2011-06-08 シグナル ファーマシューティカルズ， エルエルシー 刺激誘導性Ｉ（κ）Ｂキナーゼ［ＩＫＫ］シグナルソーム
AU740622B2 (en) * 1997-02-25 2001-11-08 Regents Of The University Of California, The IkB kinase, subunits thereof, and methods of using same
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
EP0897009A3 (en) * 1997-08-04 1999-06-09 Smithkline Beecham Plc HKABY60 polypeptides
US6030834A (en) * 1997-12-30 2000-02-29 Chiron Corporation Human IKK-beta DNA constructs and cells

Also Published As

Publication number Publication date
EP1005540B1 (en) 2004-06-16
US5939302A (en) 1999-08-17
CA2294516C (en) 2003-10-21
WO1999001542A1 (en) 1999-01-14
AU725477B2 (en) 2000-10-12
CA2294516A1 (en) 1999-01-14
ATE269402T1 (de) 2004-07-15
DE69824597D1 (de) 2004-07-22
US5916760A (en) 1999-06-29
ES2218839T3 (es) 2004-11-16
EP1005540A1 (en) 2000-06-07
JP3472584B2 (ja) 2003-12-02
EP1005540A4 (en) 2003-04-02
JP2001510347A (ja) 2001-07-31
AU8283798A (en) 1999-01-25
JP2003274984A (ja) 2003-09-30
DE69824597T2 (de) 2005-06-09
US5851812A (en) 1998-12-22

Similar Documents

Publication Publication Date Title
EP1005540A4 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
WO1999033982A3 (en) Human genes and gene expression products i
ATE366814T1 (de) Gl50 moleküle, sowie verwendungen derselben
EP0804609A4 (en) NEW GENES OF RESPONSE p53
DE69838483D1 (de) Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
DE69808743D1 (en) Netrinrezeptoren
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
ATE356137T1 (de) Neue moleküle aus der familie der tango-77- ähnlichen proteine und ihre verewendungen.
WO1996015144A3 (en) Chromosome 21 gene marker, compositions and methods using same
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
CA2281895A1 (en) Ikb kinases
MXPA02008239A (es) Gen humano de la esquizofrenia.
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
WO2000052047A3 (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
ATE245190T1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
WO2001014420A3 (en) Novel members of the plexin family and uses thereof
WO1998006841A3 (en) Two human nsp-like proteins
CA2294476A1 (en) Semaphorin receptors
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO2000019988A8 (en) NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
WO1998011234A3 (en) Human protein kinases
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
WO2001036478A3 (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides